Form 4 Tracker
Matthew B. Klein

Director; Director, CHIEF EXECUTIVE OFFICER · 7 filings · Latest: Aug 4, 2026

ClearPoint Neuro, Inc.
PTC THERAPEUTICS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERAug 4, 2026
Sale
$68.5710,292$705.7K383,868
PTCT
Klein Matthew B.—Aug 4, 2026
Proposed Sale
$68.5710,292$705.8K—
CLPT
Matthew B. KleinDirectorMay 21, 2026
Sale
$11.5916,000$185.4K46,935
CLPT
Matthew B. KleinDirectorMay 19, 2026
Option Exercise
—12,417—62,935
CLPT
MATTHEW B KLEIN—May 21, 2026
Proposed Sale
$11.5916,000$185.4K—
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERMay 14, 2026
Sale
$72.9512,572$917.2K393,998
PTCT
Klein Matthew B.—May 14, 2026
Proposed Sale
$72.462,572$186.4K—
PTCT
Klein Matthew B.—May 14, 2026
Proposed Sale
$73.0810,000$730.8K—
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERApr 21, 2026
Sale
$70.912,850$202.1K394,070
PTCT
Klein Matthew B.—Apr 21, 2026
Proposed Sale
$70.942,850$202.2K—
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERMar 12, 2026
Sale
$64.082,662$170.6K396,920
PTCT
Klein Matthew B.—Mar 12, 2026
Proposed Sale
$64.082,662$170.6K—
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERFeb 18, 2026
Sale
$69.367,371$511.3K387,082
PTCT
Klein Matthew B.—Feb 18, 2026
Proposed Sale
$69.367,371$511.2K—
PTCT
Klein Matthew B.—Jan 8, 2026
Proposed Sale
$76.452,514$192.2K—
PTCT
Klein Matthew B.—Jan 7, 2026
Proposed Sale
$77.483,016$233.7K—
PTCT
Klein Matthew B.—Jan 6, 2026
Proposed Sale
$76.955,149$396.2K—
PTCT
Klein Matthew B.—Dec 30, 2025
Proposed Sale
$76.648,089$619.9K—
PTCT
Klein Matthew B.—Dec 2, 2025
Proposed Sale
$79.073,428$271.1K—
PTCT
Klein Matthew B.—Aug 5, 2025
Proposed Sale
$51.7410,739$555.7K—

Page 1 of 2

Next →